Veterinary Clinical Sciences - Research Publications

Permanent URI for this collection

http://hdl.handle.net/11343/194098

Filters

2018 - 2019 3
Reset filters

Settings
Statistics
Citations
Author: Mansfield, Caroline × Author: Martinez Lopez, Lina × Author: Dandrieux, Julien ×

Search Results

Now showing 1 - 3 of 3
  • Item
    Thumbnail Image
    Treatment response and long term follow up in nineteen dogs diagnosed with chronic enteropathy in Australia
    Dandrieux, JRS ; Lopez, LMM ; Prakash, N ; Mansfield, CS (WILEY, 2019-09)
    Chronic enteropathy (CE) in dogs is common worldwide, but little data is available from Australia. The aim of this study was to describe treatment response and long-term outcome in a cohort of dogs with CE. Dogs were prospectively enrolled at Murdoch University and the University of Melbourne. After diagnostic investigation to rule out diseases other than CE, dogs underwent sequential therapeutic trials until achieving a clinical response (diet then antibiotics, and finally immunosuppressants). Success was defined as 75% reduction of clinical severity for a minimum of five weeks. A total of 21 dogs were enrolled, and 19 completed the study. One dog was euthanised for lack of response to treatment and one excluded for lack of owner compliance. Most dogs responded to diet (n = 10), followed by antibiotics (n = 7) and immunosuppressants (n = 2). Long-term remission (median 21.1 months, [3.0-44.7]) was achieved in eight out of ten dietary responders without additional treatment. In contrast, only two dogs with antibiotic response remained in long-term remission, of which one needed on-going antibiotic treatment. Longer term remission was achieved in the two dogs treated with immunosuppressants with on-going low dose therapy. This study concludes that most dogs referred for CE in Australia respond to dietary treatment (even after previous dietary interventions), and remission is long-term compared to dogs treated with an antibiotic. Furthermore, the need for long-term antibiotics in some dogs to maintain response may lead to antibiotic resistance. This study supports adequate dietary trials for CE in dogs, and a need for alternative second-line treatments.
  • Item
    No Preview Available
    Serum Cytokines before and after Treatment in a Cohort of Dogs with Chronic Enteropathy
    Dandrieux, J ; Santos, L ; Martinez Lopez, LM ; Mansfield, C ( 2019-06-06)
  • Item
    Thumbnail Image
    Changes in duodenal CD163-positive cells in dogs with chronic enteropathy after successful treatment
    Dandrieux, JRS ; Lopez, LMM ; Stent, A ; Jergens, A ; Allenspach, K ; Nowell, CJ ; Firestone, SM ; Kimpton, W ; Mansfield, CS (SAGE PUBLICATIONS LTD, 2018-10)
    Chronic enteropathy (CE) in dogs is characterized retrospectively per treatment response as food-responsive enteropathy (FRE), antibiotic-responsive enteropathy (ARE), and immunosuppressant-responsive enteropathy (IRE) - the latter most resembling inflammatory bowel disease in people. The aim of this study was to characterize duodenal macrophages (Mϕ) in CE using immunohistochemistry; with calprotectin (CAL) as a marker of early differentiated Mϕ and CD163 expression as a marker for resident Mϕ in the duodenum before and after treatment. Prior to treatment, dogs with FRE and IRE had a lower CD163+/CAL+ ratio than control dogs (CTRL) in crypts; this increased significantly and normalized compared with CTRL after treatment. Conversely, the CD163+/CAL+ ratio in dogs with ARE was comparable to that in healthy dogs before and after treatment. In summary, these results suggest that Mϕ play a role in the pathogenesis of CE in FRE and IRE, with a decrease in resident Mϕ and an increase in early differentiated Mϕ, but not in ARE dogs. Mϕ normalize after successful treatment.